Know How to Manage Dyslipidemia in Patients Living With HIV

Better antiretroviral therapy means more patients with HIV will face dyslipidemia and CV disease...instead of opportunistic infections.

HIV itself increases CV risk...possibly by triggering inflammatory mediators linked to atherosclerosis or platelet activation.

And early use of antiretrovirals is key...since uncontrolled HIV carries a higher risk of MI, stroke, heart failure, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote